Skip to main content

stock

CPMD · CANNAPHARMARX, INC.

What CANNAPHARMARX, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live CPMD price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on CPMD.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
708,689,905 as of 2026-08-18 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
-88.8%
Operating
-170.1%
Net
-666.2%

Returns

ROE
—
ROA
-164.2%

Health

Current ratio
0.0x
Debt/equity
—

Deep value

NCAV
-$36.39M
NCAV per share
-$0.05
Price/NCAV
Locked
NNWC
-$37.06M
NNWC per share
-$0.05
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$276,218-$138,446-$378,831-$1.91M
10-Q filed 2026-08-18
2026-03-31$627,462-$409,453-$682,343-$382,021
10-Q filed 2026-05-20
2025-12-31$138,630-$521,091-$893,553-$7.55M
10-K filed 2026-03-31
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$656,606-$440,000-$935,646-$1.48M
10-Q filed 2025-11-14
2025-06-30$231,608-$621,210-$840,980-$1.41M
10-Q filed 2026-08-18
2025-03-31$335,319-$502,607-$677,585-$690,594
10-Q filed 2026-05-20
2024-12-31$482,134-$1.97M-$1.81M-$3.74M
10-K filed 2026-03-31
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$312,164-$356,158-$515,976$188,421
10-Q filed 2025-11-14
Assets
$6.89M
Equity
-$30.83M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$1.36M-$3.35M-$11.13M-$794,621
2024-12-31$820,137-$3.63M-$9.91M-$1.70M
2023-12-31$0-$1.58M$3.69M-$2.36M
2022-12-31$0-$5.21M-$8.53M—
2021-12-31$0-$2.99M-$8.83M—
2020-12-31$0-$14.49M-$19.89M—
2019-12-31$0-$15.98M-$20.45M-$3.80M
2018-12-31$0-$954,317-$3.09M-$941,136
2017-12-31$0-$6,633-$6,633—
2016-12-31$0-$1.00M-$1.00M-$22,380

Company filings

events

  • Executive or director change, Other event

    Executive or director changeOther event
    Jan 128-K
  • Other event

    Other event
    Dec 178-K
  • Other event

    Other event
    10/10/20258-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named CPMD, and the market events around them.

Sign in to see this

Board

The CPMD board could not be loaded.

Retry the CPMD board

nakagai

Signals on CPMD come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the CPMD board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

CANNAPHARMARX, INC. (CPMD): SEC filings, financials and insider trades · Nakagai